Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Researchers at Ochsner Health and Tulane University School of Medicine have identified the genes that become active in carotid arteries when plaque rupture causes a stroke.

News | Stroke

Ochsner and Tulane Collaboration Uncovers What Happens to Genes Inside Artery Plaques to Trigger Strokes

August 15, 2022 — Researchers at Ochsner Health and Tulane University School of Medicine have identified the genes that ...

August 15, 2022

A new model developed by researchers can be used for a myriad of applications, most notably to evaluate the safety and efficacy of drugs on the cardiovascular system

News | Artificial Heart

Creating an 'Adult-Like' Mature Human Cardiac Tissue

August 15, 2022 — Researchers in the Biomedical Engineering Department at UConn have developed a new cardiac cell ...

August 15, 2022

News | ASNC

Flurpiridaz Clinical Trial Results Will be Announced at ASNC2022

August 12, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...

August 12, 2022

Older adults with atrial cardiopathy (a major, often undetected cardiac cause of stroke) may be at increased risk of developing dementia, according to new research led by Johns Hopkins Medicine.

News | Cardiovascular Clinical Studies

Johns Hopkins Researchers Find Link Between Dementia and Atrial Cardiopathy

August 12, 2022 — Older adults with atrial cardiopathy (a major, often undetected cardiac cause of stroke) may be at ...

August 12, 2022

Effect of chronic reductive stress on myocardial proteome.

News | Cardiovascular Clinical Studies

The Protein Signature Changes During Heart Disease Caused by Reductive Stress

August 8, 2022 — Two years ago, University of Alabama at Birmingham researchers and colleagues reported that reductive ...

August 08, 2022

The condition is known to increase the risk of cardiovascular disease and atherosclerosis, a buildup of fats inside the blood vessels that can constrict blood flow to the body’s tissues.

News | Heart Failure

Study Reverses Long-Held Ideas About Relationship Among Diabetes, Fat and Cardiovascular Disease

August 8, 2022 — A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond ...

August 08, 2022

The illustration shows a portion of the receptor pGC-A, known as the extracellular domain, which protrudes from cell surfaces in the cardiovascular system. Small molecules bind with the receptor and exert subtle control over blood pressure. The new research offers the first sneak peek at the full-length receptor, a vital step in the development of new drugs to treat hypertension and other afflictions.

News | Hypertension

New Study Explores Cell Receptor Crucial for Cardiovascular Health

August 8, 2022 — Cardiovascular diseases remain a leading cause of death around the world. A primary contributor to ...

August 08, 2022

About one percent of the world population is born with a congenital heart defect, which affects about 40,000 U.S. births each year, but how these particular birth defects come about is largely unknown.

News | Congenital Heart

New Study Provides Insight for How Congenital Heart Defects Manifest

August 2, 2022 — About one percent of the world population is born with a congenital heart defect, which affects about ...

August 02, 2022

RADIANCE II US FDA IDE pivotal trial evaluating the Paradise Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant reduction in daytime ambulatory systolic blood pressure between treatment and a sham procedure measured at two months

News | Hypertension

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise System for the Treatment of Hypertension

July 29, 2022 — ReCor Medical, Inc. and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings ...

July 29, 2022

a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes

News | Embolization devices

Instylla Announces Positive Results From Preclinical Studies of Embrace Hydrogel Embolic System in Hemorrhage Models

July 28, 2022 — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

July 28, 2022

News | Sudden Cardiac Arrest

Main Line Health, Mayo researchers find natural product may prevent sudden cardiac death from rare inherited syndromes

July 28, 2022 — In 2020, a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part ...

July 28, 2022

The world’s first HIV-positive to HIV-positive heart transplant has been successfully performed at Montefiore Health System in the Bronx.

News | Heart Failure

World’s First HIV-Positive to HIV-Positive Heart Transplant Performed at Montefiore Health System

July 27, 2022 — The world’s first HIV-positive to HIV-positive heart transplant has been successfully performed at Monte ...

July 27, 2022

Dr Aamir Hameed, Lecturer in the Department of Anatomy and Regenerative Medicine and a Principal Investigator with the Tissue Engineering Research Group at RCSI University of Medicine and Health Sciences

News | Heart Failure

New Heart Model to Help Treat Patients with Heart Failure

July 27, 2022 — Researchers from RCSI University of Medicine and Health Sciences have developed a new lab-based model of ...

July 27, 2022

Trial was negatively impacted by the COVID-19 pandemic and did not meet the primary endpoint

News | Pharmaceuticals

dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes Trial Results Published in European Heart Journal

July 25, 2022 DalCor Pharmaceuticals announced the results of the dal-GenE Phase 3 cardiovascular precision medicine ...

July 25, 2022

that Dhanunjaya DJ Lakkireddy, MD, Medical Director for the Kansas City Heart Rhythm Institute, will initiate a research protocol analyzing the signals acquired by the PURE EP System during Radiofrequency (RF) ablation

News | Cardiovascular Clinical Studies

BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute

July 22, 2022 — BioSig Technologies, Inc. a medical technology company advancing electrophysiology workflow by ...

July 22, 2022